R-410A than other refrigerants. R-410A systems thus require service personnel to use different tools, equipment, safety standards, and techniques. Equipment manufacturers are aware of these changes and require the certification of professionals installing R-410A systems. In addition, the AC&R Safety Coalition has been created to help educate professionals about R-410A systems. In accordance with terms and agreement reached in the Montreal Protocol (The Montreal Protocol on Substances that Deplete the Ozone Layer) the United States Environmental Protection Agency has mandated that production or import of R-22 along with other hydrochlorofluorocarbons (HCFCs) be phased out in the United States. In the EU
Wiley protocol at separate times throughout the period. The protocol is promoted as differing from conventional hormone replacement therapy in several ways: The protocol also includes a follow-up program to monitor the serum of the bioidentical hormones. Wiley has stated that in her opinion, the most important aspect of the protocol is the specific schedule and levels of the hormone doses rather than their bioidentical nature. A patent was granted for the protocol in 2011 for the specific blend of hormones and dosing method. Concerns have been raised that serum levels may not be an acceptable marker for transdermally administered hormones, that